St. Jude’s warning about battery risks in its implanted heart devices are big but will likely not disrupt its deal with Abbott Labs , said TheStreet’s Jim Cramer. Shares of St. Jude Medical are down Tuesday after the medical device maker warned patients that batteries in its implanted heart devices could deplete prematurely. “There have been two deaths that have been associated with the loss of defibrillation therapy as a result of premature battery depletion,” St. Jude VP of Quality Control Jeff Fecho said in the letter to physicians.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
